The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.
about
Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study.Immunotherapy for urothelial carcinoma: current status and perspectives.Macrophage-based cell therapies: The long and winding roadDevelopment, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.Defining Genome-Wide Expression and Phenotypic Contextual Cues in Macrophages Generated by Granulocyte/Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Heat-Killed Mycobacteria.
P2860
The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The application of adjuvant au ...... multicenter, randomized trial.
@ast
The application of adjuvant au ...... multicenter, randomized trial.
@en
type
label
The application of adjuvant au ...... multicenter, randomized trial.
@ast
The application of adjuvant au ...... multicenter, randomized trial.
@en
prefLabel
The application of adjuvant au ...... multicenter, randomized trial.
@ast
The application of adjuvant au ...... multicenter, randomized trial.
@en
P2093
P2860
P356
P1476
The application of adjuvant au ...... multicenter, randomized trial.
@en
P2093
Bertrand Tombal
Bonnie Mills
Domján Zsolt
Fernando J Jimenz-Cruz
Gerard Benoit
Imre Romics
Jeff Sherman
Joachim W Thüroff
Jozsef Kondas
Laszlo Kisbenedek
P2860
P2888
P356
10.1186/1479-5876-8-54
P577
2010-06-08T00:00:00Z
P5875
P6179
1042636772